SAVAYSA Drug Profile, 2024: SAVAYSA (edoxaban tosylate) drug patents, FDA exclusivity, litigation, drug prices

by DrugPatentWatch

SAVAYSA Drug Profile, 2024

This report focuses on SAVAYSA and covers the following critical aspects of this drug:

United States patentsFDA Paragraph IV patent challengesEuropean supplementary protection certificates (SPCs)Clinical trialsDrug pricesFinished product suppliersRaw active pharmaceutical ingredient (API) sourcesFREE UPDATE: Send your receipt to DrugPatentWatch within 30 days for a free updat

• Format: Paperback
• Language: English
• ISBN: B0CS5W9QPV
• ISBN13: 9798875808166
• Release Date: January 2024
• Publisher: Independently Published
• Length: 166 Pages
• Weight: 0.88 lbs.
• Dimensions: 0.3" x 8.5" x 11.0"